TNSN03124A1 - ADENOSINE A2A RECEPTOR AGONIST AND COMBINED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIR CONDITIONS - Google Patents
ADENOSINE A2A RECEPTOR AGONIST AND COMBINED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIR CONDITIONSInfo
- Publication number
- TNSN03124A1 TNSN03124A1 TNPCT/EP2002/005725A TNSN03124A TNSN03124A1 TN SN03124 A1 TNSN03124 A1 TN SN03124A1 TN SN03124 A TNSN03124 A TN SN03124A TN SN03124 A1 TNSN03124 A1 TN SN03124A1
- Authority
- TN
- Tunisia
- Prior art keywords
- treatment
- anticholinergic agent
- receptor agonist
- adenosine
- combined
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENTION CONCERNE UNE ASSOCIATION D'UN AGONISTE DE RECEPTEUR D'ADENOSINE A2A SELECTIF ET D'UN AGENT ANTICHOLINERGIQUE POUR L'ADMINISTRATION SIMULTANEE, SEQUENTIELLE OU DISTINCTE PAR INHALATION DANS LE TRAITEMENT D'UNE MALADIE OBSTRUCTIVE DES VOIES AERIENNES OU D'UNE AUTRE MALADIE INFLAMMATOIRE, SOUS RESERVE QUE L'AGENT ANTICHOLINERGIQUE NE SOIT PAS UN SEL DE TIOTROPIUM.THE PRESENT INVENTION CONCERNS A COMBINATION OF A SELECTIVE ADENOSINE A2A RECEPTOR AGONIST AND AN ANTICHOLINERGIC AGENT FOR SIMULTANEOUS, SEQUENTIAL OR DISTINCT ADMINISTRATION BY INHALATION IN THE TREATMENT OF OBSTRUCTIVE AIRWAY OR OTHER DISEASE INFLAMMATORY DISEASE, PROVIDED THAT THE ANTICHOLINERGIC AGENT IS NOT A SALT OF TIOTROPIUM.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29384201P | 2001-05-25 | 2001-05-25 | |
GB0129275A GB0129275D0 (en) | 2001-12-06 | 2001-12-06 | Pharmaceutical combination |
GB0210238A GB0210238D0 (en) | 2002-05-03 | 2002-05-03 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN03124A1 true TNSN03124A1 (en) | 2005-12-23 |
Family
ID=42632507
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNPCT/EP2002/005725A TNSN03124A1 (en) | 2001-05-25 | 2002-05-24 | ADENOSINE A2A RECEPTOR AGONIST AND COMBINED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIR CONDITIONS |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR036030A1 (en) |
EA (1) | EA200301153A1 (en) |
PE (1) | PE20030145A1 (en) |
TN (1) | TNSN03124A1 (en) |
-
2002
- 2002-05-24 EA EA200301153A patent/EA200301153A1/en unknown
- 2002-05-24 AR ARP020101928 patent/AR036030A1/en not_active Application Discontinuation
- 2002-05-24 TN TNPCT/EP2002/005725A patent/TNSN03124A1/en unknown
- 2002-05-24 PE PE2002000439A patent/PE20030145A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EA200301153A1 (en) | 2004-04-29 |
AR036030A1 (en) | 2004-08-04 |
PE20030145A1 (en) | 2003-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN03123A1 (en) | PDE 4 INHIBITOR AND ASSOCIATED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIRWAY DISEASES | |
MXPA03010787A (en) | An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases. | |
NZ522326A (en) | Adenosine A2A receptor antagonists | |
JO2503B1 (en) | Benzothiazole derivatives | |
AU4438601A (en) | Therapeutic combinations of antihypertensive and antiangiogenic agents | |
YU42703A (en) | Compounds specific to adenosine a1, a2a and a3 receptor and uses thereof | |
WO2007064658A3 (en) | Safe and effective methods of administering therapeutic agents | |
WO2009045309A3 (en) | Use of v2 receptor antagonists in combination with vasopressinergic agonists | |
MXPA03009185A (en) | Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson s disease. | |
WO2004096118A3 (en) | Composition for improving cognition and memory | |
BR0105776A (en) | Combination treatment for depression, anxiety and psychosis | |
TNSN03124A1 (en) | ADENOSINE A2A RECEPTOR AGONIST AND COMBINED ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE AIR CONDITIONS | |
WO2001017558A3 (en) | Novel uses of mammalian ccr6 receptors and related reagents | |
TWI256388B (en) | Pharmaceutical combination | |
ATE277639T1 (en) | COMPOSITIONS OF ADENOSINE A1 AGONISTS AND 5HT3 AGONISTS | |
ATE260118T1 (en) | COMPOSITIONS OF ADENOSINE A1 AGONISTS WITH 5HT1 AGONISTS | |
GB0028245D0 (en) | New therapeutic use | |
BR9912008A (en) | Treatment method | |
WO2001045686A3 (en) | Formulations of adenosine a1 agonists | |
TNSN04102A1 (en) | ASSOCIATION OF A SELECTIVE PDE4 INHIBITOR AND A BETA-2 ADRENERGIC RECEPTOR AGONIST | |
ECSP034863A (en) | AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES | |
HN2002000128A (en) | AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS. | |
EA200301140A1 (en) | PDE4 INHIBITOR AND ANTICHOLINERGIC AGENT IN COMBINATION FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF RESPIRATORY WAYS |